Literature DB >> 3941767

Efficacy of primidone in essential tremor.

W C Koller, V L Royse.   

Abstract

Primidone, 50 to 1,000 mg/d, reduced the amplitude of essential tremor in both untreated and propranolol-treated patients. Low doses were as effective as high doses. Primidone decreased tremor more than propranolol. There was no correlation between therapeutic response and serum levels. Acute reactions to the initial dose and side effects of higher doses caused drug intolerance. A single oral dose (250 mg) decreased tremor by 60% 1 to 7 hours after ingestion, with stable serum primidone levels but no detectable phenobarbital levels. Tremor control was lost when phenobarbital was substituted for primidone. Primidone is an effective agent for the treatment of essential tremor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941767     DOI: 10.1212/wnl.36.1.121

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Essential Tremor.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-03       Impact factor: 3.598

2.  Primidone and essential tremor.

Authors:  S Seyfert; A Honé; G Holl
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

Review 3.  Differential diagnosis of common tremor syndromes.

Authors:  R Bhidayasiri
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 4.  Pharmacotherapy of essential tremor : an overview of existing and upcoming agents.

Authors:  Kelly E Lyons; Rajesh Pahwa
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 5.  The clinical use of barbiturates in neurological disorders.

Authors:  M C Smith; B J Riskin
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 6.  Pharmacological management of essential tremor.

Authors:  Reza Sadeghi; William G Ondo
Journal:  Drugs       Date:  2010-12-03       Impact factor: 9.546

Review 7.  Management of essential tremor.

Authors:  Theresa A Zesiewicz; Elmyra Encarnacion; Robert A Hauser
Journal:  Curr Neurol Neurosci Rep       Date:  2002-07       Impact factor: 5.081

Review 8.  Benefits and risks of pharmacological treatments for essential tremor.

Authors:  Kelly E Lyons; Rajesh Pahwa; Cynthia L Comella; Mahmood S Eisa; Rodger J Elble; Stanley Fahn; Joseph Jankovic; Jorge L Juncos; William C Koller; William G Ondo; Kapil D Sethi; Matthew B Stern; Caroline M Tanner; Ron Tintner; Ray L Watts
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 9.  Treatment of essential tremor: a systematic review of evidence and recommendations from the Italian Movement Disorders Association.

Authors:  Mario Zappia; Alberto Albanese; Elisa Bruno; Carlo Colosimo; Graziella Filippini; Paolo Martinelli; Alessandra Nicoletti; Graziella Quattrocchi; Giovanni Abbruzzese; Alfredo Berardelli; Roberta Allegra; Maria Stella Aniello; Antonio E Elia; Davide Martino; Daniela Murgia; Marina Picillo; Giovanna Squintani
Journal:  J Neurol       Date:  2012-08-11       Impact factor: 4.849

10.  Deep brain stimulation in essential tremor: targets, technology, and a comprehensive review of clinical outcomes.

Authors:  Joshua K Wong; Christopher W Hess; Leonardo Almeida; Erik H Middlebrooks; Evangelos A Christou; Erin E Patrick; Aparna Wagle Shukla; Kelly D Foote; Michael S Okun
Journal:  Expert Rev Neurother       Date:  2020-03-02       Impact factor: 4.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.